Profil
Edgar D.
Charles is Chief Medical Officer at Climb Bio, Inc. since 2025.
Dr. Charles was Vice President at Bristol Myers Squibb Co. from 2015 to 2025.
Dr. Charles completed undergraduate studies at The University of Chicago, graduate studies at The Rockefeller University, and earned a doctorate from The University of Alabama School of Medicine.
Postes actifs de Edgar Charles
| Sociétés | Poste | Début |
|---|---|---|
| CLIMB BIO, INC. | Directeur Technique/Scientifique/R&D | 18/06/2025 |
Anciens postes connus de Edgar Charles
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2025 |
Formation de Edgar Charles
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama School of Medicine
The University of Alabama School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
















